Doctor Matthew has filed 4 insider transactions across 1 company since February 2024.
Most recent transaction: a grant/award of 16500 shares of REGIS CORP ($RGS) on November 22, 2024.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 22, 2024 | REGIS CORP | $RGS | Doctor Matthew | President and CEO | A | Common Stock | 16500 | $0.00 | 19,584.0000 | 2,343,000 | 535.02% | 0.70% |
| Nov. 5, 2024 | REGIS CORP | $RGS | Doctor Matthew | President and CEO | F | Common Stock | 547 | $23.37 | 3,084.0000 | 2,343,000 | 15.06% | 0.02% |
| Nov. 5, 2024 | REGIS CORP | $RGS | Doctor Matthew | President and CEO | F | Common Stock | 339 | $23.37 | 3,292.0000 | 2,343,000 | 9.34% | 0.01% |
| Feb. 8, 2024 | REGIS CORP | $RGS | Doctor Matthew | President and CEO | F | Common Stock | 211 | $12.35 | 76,671.0000 | 2,323,000 | 0.27% | 0.01% |